About
TympaHealth is a digital health company that uses patented, award-winning technology to allow for comprehensive hearing health assessments to be performed in point-of-care settings, enabling earlier disease detection and access to cost-effective care. TympaHealth is CE marked and FDA registered and the only solution of its kind dedicated to the democratization of ear and hearing care. With the recent FDA-approval of hearing devices to be allowed for sale over-the-counter in the U.S., TympaHealth is well positioned to help point-of-care providers in non-traditional settings perform comprehensive exams to detect disease and assist patients to make the right hearing device decisions. TympaHealth is an NHS spin-out and is also proud to announce that KHP MedTech Innovations, a collaboration between Guy’s and St. Thomas’ NHS Trust, King’s College Hospital NHS Foundation Trust and King's College London has invested in this seed round.“Tympa is the perfect combination of intuitive technology and improved access to care that is driving our next generation patient-centric approach to earlier disease detection and modification,” said Anil Sethi, former Apple Health Executive and Founder of Gliipmse and Ciitizen.